Literature DB >> 24759708

Isolation and identification of an Enterobacter cloacae strain producing a novel subtype of Shiga toxin type 1.

William S Probert1, Cassandra McQuaid2, Kimmi Schrader2.   

Abstract

We describe here the isolation and identification of a Shiga toxin 1 (Stx1)-producing Enterobacter cloacae strain, M12X01451, from a human clinical specimen. The bacterial isolate was identified as E. cloacae using a polyphasic approach that included phenotypic, genetic, and proteomic analyses. The M12X01451 stx1 was sequenced, and the holotoxin was found to share only 87% amino acid sequence identity with the nearest Stx1 subtype reference sequence. Sequence analysis of the regions immediately flanking stx1 displayed similarities with bacteriophage-related sequences, suggesting a prophage origin. The stx1 gene was a stable element within the M12X01451 genome, as demonstrated by real-time PCR detection following successive subculturing of the bacterial isolate. Culture supernatant from M12X01451 was cytotoxic to Vero cells but was not neutralized by an anti-Stx1 monoclonal antibody. In addition, Stx1 from M12X01451 demonstrated limited antigenicity with two commercially available lateral flow immunoassays. The M12X01451 Stx represents a new Stx1 subtype based on the degree of sequence dissimilarity with Stx1 subtype reference sequences and its limited reactivity with anti-Stx1 antibodies.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759708      PMCID: PMC4097712          DOI: 10.1128/JCM.00338-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin.

Authors:  Christine Bürk; Richard Dietrich; Gabriele Açar; Maximilian Moravek; Michael Bülte; Erwin Märtlbauer
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting.

Authors:  Tim Schuurman; Richard F de Boer; Anna M D Kooistra-Smid; Anton A van Zwet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

4.  Human isolates of Aeromonas possess Shiga toxin genes (stx1 and stx2) highly similar to the most virulent gene variants of Escherichia coli.

Authors:  A Alperi; M J Figueras
Journal:  Clin Microbiol Infect       Date:  2010-10       Impact factor: 8.067

5.  A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity.

Authors:  H Ling; N S Pannu; A Boodhoo; G D Armstrong; C G Clark; J L Brunton; R J Read
Journal:  Structure       Date:  2000-03-15       Impact factor: 5.006

6.  Phenotypic and genotypic properties of the genus Hafnia.

Authors:  J Michael Janda; Sharon L Abbott; Shideh Khashe; Will Probert
Journal:  J Med Microbiol       Date:  2002-07       Impact factor: 2.472

7.  Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR.

Authors:  Gehua Wang; Clifford G Clark; Frank G Rodgers
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

8.  Multiplex real-time PCR method to identify Shiga toxin genes stx1 and stx2 and Escherichia coli O157:H7/H- serotype.

Authors:  Karen C Jinneman; Ken J Yoshitomi; Stephen D Weagant
Journal:  Appl Environ Microbiol       Date:  2003-10       Impact factor: 4.792

9.  Comparative genomics and stx phage characterization of LEE-negative Shiga toxin-producing Escherichia coli.

Authors:  Susan R Steyert; Jason W Sahl; Claire M Fraser; Louise D Teel; Flemming Scheutz; David A Rasko
Journal:  Front Cell Infect Microbiol       Date:  2012-11-07       Impact factor: 5.293

10.  Clinical significance of Escherichia albertii.

Authors:  Tadasuke Ooka; Kazuko Seto; Kimiko Kawano; Hideki Kobayashi; Yoshiki Etoh; Sachiko Ichihara; Akiko Kaneko; Junko Isobe; Keiji Yamaguchi; Kazumi Horikawa; Tânia A T Gomes; Annick Linden; Marjorie Bardiau; Jacques G Mainil; Lothar Beutin; Yoshitoshi Ogura; Tetsuya Hayashi
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

View more
  17 in total

1.  An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coli.

Authors:  Craig Skinner; Guodong Zhang; Stephanie Patfield; Xiaohua He
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

2.  Characterization of Atypical Shiga Toxin Gene Sequences and Description of Stx2j, a New Subtype.

Authors:  Alexander Gill; Forest Dussault; Tanis McMahon; Nicholas Petronella; Xiong Wang; Elizabeth Cebelinski; Flemming Scheutz; Kelly Weedmark; Burton Blais; Catherine Carrillo
Journal:  J Clin Microbiol       Date:  2022-03-16       Impact factor: 11.677

Review 3.  The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing Pathogen Escherichia albertii.

Authors:  Shantanu Bhatt; Marisa Egan; Brian Critelli; Andrew Kouse; Daniel Kalman; Chirag Upreti
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

4.  Identification and pathogenomic analysis of an Escherichia coli strain producing a novel Shiga toxin 2 subtype.

Authors:  Xiangning Bai; Shanshan Fu; Ji Zhang; Ruyue Fan; Yanmei Xu; Hui Sun; Xiaohua He; Jianguo Xu; Yanwen Xiong
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

5.  Virulence Potential of Activatable Shiga Toxin 2d-Producing Escherichia coli Isolates from Fresh Produce.

Authors:  Angela R Melton-Celsa; Alison D O'Brien; Peter C H Feng
Journal:  J Food Prot       Date:  2015-11       Impact factor: 2.077

6.  New Monoclonal Antibodies against a Novel Subtype of Shiga Toxin 1 Produced by Enterobacter cloacae and Their Use in Analysis of Human Serum.

Authors:  Craig Skinner; Stephanie Patfield; Rowaida Khalil; Qiulian Kong; Xiaohua He
Journal:  mSphere       Date:  2016-02-17       Impact factor: 4.389

7.  Shiga Toxin 1-Producing Shigella sonnei Infections, California, United States, 2014-2015.

Authors:  Katherine Lamba; Jennifer A Nelson; Akiko C Kimura; Alyssa Poe; Joan Collins; Annie S Kao; Laura Cruz; Gregory Inami; Julie Vaishampayan; Alvaro Garza; Vishnu Chaturvedi; Duc J Vugia
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

8.  Recent Outbreaks of Shigellosis in California Caused by Two Distinct Populations of Shigella sonnei with either Increased Virulence or Fluoroquinolone Resistance.

Authors:  Varvara K Kozyreva; Guillaume Jospin; Alexander L Greninger; James P Watt; Jonathan A Eisen; Vishnu Chaturvedi
Journal:  mSphere       Date:  2016-12-21       Impact factor: 4.389

9.  Effect of the Food Additives Sodium Citrate and Disodium Phosphate on Shiga Toxin-Producing Escherichia coli and Production of stx-Phages and Shiga toxin.

Authors:  Lucas J Lenzi; Paula M A Lucchesi; Lucía Medico; Julia Burgán; Alejandra Krüger
Journal:  Front Microbiol       Date:  2016-06-23       Impact factor: 5.640

10.  Mass Spectrometry-Based Method of Detecting and Distinguishing Type 1 and Type 2 Shiga-Like Toxins in Human Serum.

Authors:  Christopher J Silva; Melissa L Erickson-Beltran; Craig B Skinner; Stephanie A Patfield; Xiaohua He
Journal:  Toxins (Basel)       Date:  2015-12-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.